Kasahara, A <br/><br/>
Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response.  [electronic resource] 

 -  Journal of hepatology  Mar 1997 
 - 574-83 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0168-8278 
<br/><br/><label>Standard No.: </label>10.1016/s0168-8278(97)80423-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alanine Transaminase--blood<br/>Antibodies, Viral--immunology<br/>Antiviral Agents--administration & dosage<br/>Biomarkers--blood<br/>Chronic Disease<br/>Collagenases--blood<br/>Female<br/>Follow-Up Studies<br/>Gelatinases--blood<br/>Genome, Viral<br/>Glycoproteins--blood<br/>Hepacivirus--genetics<br/>Hepatitis C--enzymology<br/>Humans<br/>Immunoenzyme Techniques<br/>Injections, Intravenous<br/>Interferon-beta--administration & dosage<br/>Liver Cirrhosis--enzymology<br/>Male<br/>Matrix Metalloproteinase 1<br/>Matrix Metalloproteinase 2<br/>Metalloendopeptidases--blood<br/>Middle Aged<br/>Polymerase Chain Reaction<br/>Protease Inhibitors--blood<br/>Proteins--metabolism<br/>RNA, Viral--analysis<br/>Tissue Inhibitor of Metalloproteinase-2<br/>Tissue Inhibitor of Metalloproteinases<br/>Treatment Outcome